Falch Lecture 2021: Professor Robert S. Langer
Professor Robert S. Langer, Massachusetts Institute of Technology, "The Edison of Medicine", will present the Falch Lecture entitled "Creating and implementing breakthrough technologies in biotechnology and nanotechnology". Social event at Eitri lab after the lecture.
November 9, at 17:00 – 18:00, Professor Robert S. Langer, Massachusetts Institute of Technology, will present the Falch Lecture entitled Creating and implementing breakthrough technologies in biotechnology and nanotechnology. The lecture will be streamed live. Dr. Langer has been called "The Edison of Medicine", and he has an exceptional record in science and innovation.
The event will be followed by a social event with food at Eitri Medical Incubator 18:00 - 20:00
Registration link for both events in the info box to the right. Please note that you need to be present to attend the live stream, it will not be distributed by email or published in this event. The social event at Eitru Lab is hosted by Eitri Medical Incubator, toghether with CCBIO and NeuroSysMed. The registration is not obligatory for attending the lecture or event at Eitri.
About Robert S. Langer:
Robert Langer is an internationally acclaimed inventor and engineer, and one of 12 Institute Professors at the Massachusetts Institute of Technology (MIT), the highest honor awarded to a faculty member. Langer has published more than 1500 scientific articles and has more than 1400 issued or pending patents. His scientific discoveries and entrepreneurial activities made him a pioneer in the fields of drug delivery, tissue engineering, and nanotechnology. He has founded or cofounded more than 40 biotechnology companies, and his students are now leading over 200 companies and research groups around the globe.
Langer’s career was significantly shaped during a postdoctoral fellowship with cancer researcher and surgeon Dr. Judah Folkman at the Children’s Hospital Boston and at Harvard Medical School from 1974-1977. During these years, Langer developed new and innovative technologies, focusing on two projects: trying to restrict tumor growth by changing how blood vessels formed, and by developing controlled-release drug delivery systems.
Unlike many of his academic peers, the journey of Langer’s scientific work often results in the issuing of a license to a pharmaceutical, chemical, biotechnology or medical device company, or in the creation of a spin-off. A well-known example is Moderna, which he co-founded in 2010, together with stem cell biologist Derrick Rossi and others.